Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year High at $42.35

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) reached a new 52-week high during trading on Monday . The stock traded as high as $42.35 and last traded at $41.72, with a volume of 41301 shares changing hands. The stock had previously closed at $42.15. Analyst Upgrades and Downgrades Separately, StockNews.com upgraded Amphastar Pharmaceuticals from a […]

Related Keywords

Williamj Peters , ,Amphastar Pharmaceuticals ,Pricet Rowe Associates Inc ,Amphastar Pharmaceuticals Stock Performance ,Amphastar Pharmaceuticals Company Profile ,Pacer Advisors Inc ,Insider Activity At Amphastar Pharmaceuticals ,Amphastar Pharmaceuticals Inc ,News Ratings For Amphastar Pharmaceuticals Daily ,Goldman Sachs Group Inc ,Nasdaq ,Mesirow Institutional Investment Management Inc ,Get Rating ,Institutional Investment Management ,Street Corp ,Goldman Sachs Group ,Sachs Group ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredients Products ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Stocks ,Technicals ,